Literature DB >> 6301812

Measurement of receptor-independent metabolism of low-density lipoprotein. An application of glycosylated low-density lipoprotein.

J Sasaki, T Okamura, G L Cottam.   

Abstract

Incubation of human low-density lipoprotein (LDL) with glucose results in a nonenzymatic formation of a Schiff base between the monosaccharide and lysyl residues of apolipoprotein B. Increasing the percentage of lysyl residues of apolipoprotein B modified by glycosylation decreases the fractional catabolic rate of the glycosylated LDL, and decreases the metabolism of the glycosylated LDL by human skin fibroblasts. The glycosylated LDL, containing 20-40% of total lysyl residues of apoprotein B modified, was metabolized at a slow rate by both human skin fibroblasts and mouse peritoneal macrophages. These results led to the suggestion that glycosylated LDL is primarily catabolized via a receptor-independent process. Assuming LDL catabolism occurs via receptor-dependent and receptor-independent processes, the ratio of (fractional catabolic rate of glycosylated LDL)/(fractional catabolic rate of native LDL) should be an estimate of the percentage of LDL catabolism via the receptor-independent process. From the fractional catabolic rates of glucose-LDL (20-40% of lysyl residues modified) and galactose-LDL (30-60% of lysyl residues modified) 41% and 30% respectively, of LDL catabolism occurred by a receptor-independent process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301812     DOI: 10.1111/j.1432-1033.1983.tb07294.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus.

Authors:  W Kortlandt; C Benschop; H J van Rijn; D W Erkelens
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

2.  Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis.

Authors:  J V Hunt; M A Bottoms; K Clare; J T Skamarauskas; M J Mitchinson
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

3.  Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

Authors:  J L Witztum; U P Steinbrecher; Y A Kesaniemi; M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.